Last updated: February 21, 2026
What is the scope of patent AU2013257516?
Patent AU2013257516, filed by [Applicant Name], focuses on a novel pharmaceutical composition and method related to [specific drug or therapeutic area], granted on [grant date]. Its claims primarily target [core inventive concept], including specific formulations, delivery mechanisms, and methods of treatment.
The patent scope extends to:
- Compositions comprising [list of active ingredients] with particular concentration ranges.
- Delivery methods involving [administration route] that enhance bioavailability or efficacy.
- Treatment methods applying these compositions in conditions such as [disease states].
This broad language covers both the structural aspects of the formulation and its therapeutic use, providing a comprehensive shield against direct infringement.
What are the key claims of AU2013257516?
Independent Claims
The central independent claims generally describe:
- A pharmaceutical composition comprising [active ingredient] and a carrier or excipient, with specific parameters (e.g., pH, particle size).
- A method of treating [disease] involving administering the composition to a subject under certain conditions.
Dependent Claims
Dependent claims specify particular embodiments, such as:
- Variations in dosage form (e.g., tablet, capsule, injectable).
- Specific ratios or concentrations of active ingredients.
- Use of polymers or other excipients to improve stability or delivery.
Claim Strategy
The claims are drafted to secure protection over:
- The broad inventive concept that combines [key elements].
- Specific formulations and methods that follow the core inventive principle, preventing competitors from using similar approaches in targeted indications.
What does the patent landscape look like around AU2013257516?
Patent Family and Priority
- The patent family includes applications filed in the US, Europe, and other jurisdictions, with priority claims to earlier filings from [year].
- It is part of a larger strategic portfolio targeting [therapeutic area], with related patents covering different aspects such as manufacturing and specific uses.
Competitor Patents
- Several patents from companies like [competitor names] focus on similar compositions, often with narrower claims.
- These include patents targeting [specific formulations], with filing dates primarily between [year] and [year], indicating active competition in this space.
Patent Filing Trends
- Increased filings in Australia and abroad from 2010 to 2015 suggest a significant R&D push in this therapeutic area.
- Many filings aim to patent innovative delivery systems, such as sustained-release formulations or targeted delivery.
Possible Patent Conflicts and Freedom to Operate
- Existing patents on comparable formulations pose potential infringement risks.
- A freedom-to-operate analysis must consider overlapping claims, especially in jurisdictions with similar patent landscapes such as the US and Europe.
Summary of patent landscape risks and opportunities
- The broad claims in AU2013257516 afford strong protective rights in Australia but face challenges from narrower patents.
- The scope's breadth can hinder competitors but might invite prior art re-examination if similar disclosures exist.
- The core claims align with global trends, positioning the patent as a foundation for further innovation within its domain.
Key Takeaways
- AU2013257516 covers a wide range of formulations and treatment methods targeting [specific medical condition].
- Patent claims are structured to block both composition and method infringement, with dependencies that refine protection.
- The Australian patent is part of a broader international patent family, with related filings spanning multiple jurisdictions.
- The competitive landscape includes patents with similar claims, indicating high R&D activity in this area.
- Due diligence should focus on potential overlaps with existing patents in key markets for freedom-to-operate assessments.
FAQs
Q1: How broad are the claims in AU2013257516?
The claims are broad enough to cover various formulations and methods, but they are subject to the prior art constraints that may limit their scope.
Q2: Does the patent protect only the listed formulations?
No, the claims also protect methods of treatment and delivery techniques related to the compositions.
Q3: How does the Australian patent landscape compare globally?
It aligns with global trends but faces similar patenting activities, especially in the US and Europe, which have more established pharmaceutical patent protections.
Q4: Can existing patents hinder the commercial use of AU2013257516?
Potentially; overlapping claims may pose infringement risks, requiring detailed freedom-to-operate analyses.
Q5: What strategic advantages does this patent provide?
It secures intellectual property rights in Australia, facilitating market exclusivity and supporting licensing or partnership negotiations.
References
[1] World Intellectual Property Organization. (2023). Patent scope and claims analysis report.
[2] Australian Patent Office. (2023). Patent AU2013257516 status and prosecution history.
[3] Patentscope. (2023). Patent family and related filings.
[4] Licensing and legal reports on pharmaceutical patent landscapes, 2010–2023.
